ML at Sloan Kettering Cancer Center

For a long time, physicians have recognized that the tools they have aren't powerful enough to treat complex diseases, like cancer. In addition to data science and models, clinicians also needed actual products — tools that physicians and researchers can draw upon to answer questions they regularly confront, such as “what clinical trials are available for this patient that I'm seeing right now?” In this episode, our host Kyle interviews guests Alex Grigorenko and Iker Huerga from Memorial Sloan Kettering Cancer Center to talk about how data and technology can be used to prevent, control and ultimately cure cancer.

Guests

Alex Grigorenko: Alex Grigorenko is the lead data scientist of the Data Products Team, a multidisciplinary software development team of designers, engineers and data scientists, at Memorial Sloan Kettering (MSK). Prior to that, he worked as a statistical analyst on MSK’s Strategic Initiatives and Quantitative Analysis Team. Alex holds an M.S. in Biostatistics from Harvard University’s School of Public Health and a B.S. in mathematical decision sciences from the University of North Carolina, Chapel Hill.

Iker Huerga